Saying 1,000 words: 'Selfies' could to improve medication adherence

Cara Livernois | | Health Exec | Precision Medicine

Monitoring medication adherence may take a step forward with smartphone apps that require patients to snap 'selfies' before and after they take medication.

Appropriately titled “selfie medicine,” the app requires patients to take medications and then upload video proof to their clinic. This new avenue of remote patient monitoring aims to increase medication adherence.

Additionally, these types of monitoring apps are being researched with funding provided by the National Institute on Drug Abuse to see if patients with opioid addictions could use the app to avoid a relapse.

"If we can keep patients engaged, we can keep them in treatment longer," lead researcher Judith Tsui, of the University of Washington School of Medicine in Seattle, told the New York Times.

Read the full story below:

Selfie Medicine: Phone Apps Push People to Take Their Pills

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.